Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RevoLix HTL

K-Number: K211534 · 2022-05-19

Decision Date2022-05-19
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

RevoLix HTL is a medical device manufactured by Lisa Laser Products GmbH. It received FDA 510(k) clearance on 2022-05-19 under approval number K211534. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RevoLix HTL?

RevoLix HTL is a medical device that received FDA 510(k) clearance on 2022-05-19. It is manufactured by Lisa Laser Products GmbH. The 510(k) number is K211534.

When was RevoLix HTL approved by the FDA?

RevoLix HTL received FDA 510(k) clearance on 2022-05-19, under approval number K211534.

What company makes RevoLix HTL?

RevoLix HTL is manufactured by Lisa Laser Products GmbH.

What is the FDA product code for RevoLix HTL?

The FDA product code for RevoLix HTL is GEX. This falls under the Gastroenterology category.

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.